Data / Form D filings / Havah Therapeutics, Inc.
Havah Therapeutics, Inc.: Form D filing
Havah Therapeutics, Inc., a pharmaceuticals company in Longmont, CO, filed a Form D with the SEC in 2024. The latest, on May 30, 2024, reports $507,434 sold of a $507,434 offering to 14 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2112 ANDREW ALDEN ST, Longmont, CO, 80504
- Phone
- (303) 717-9446
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2025011
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 30, 2024 | New notice | $507,434 | $507,434 | 14 | May 17, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ronald Martell | Director | |
| Matthew Brewer | Executive Officer, Director | |
| Jim Weiss | Director |
Every Form D from the week of May 27, 2024 · All recent filings in Colorado · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Havah Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.